About: Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. Its customers include hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.07 (-14.91%)
AURX NYSE Nuo Therapeutics Inc
Nuo Therapeutics Inc share price
AURX price activity
Last Price
$1.070
Change (24hr)
-0.19 USD (14.91%)
Volume
1K
Volume (4w avg)
-
Open
$1.20
Day Range
$1.07 - $1.20
Previous Close
$1.26
Last Trade
05 Nov, 4:54 pm GMT+0
Delayed
05 Nov, 4:54 pm GMT+0
AURX price performance
Delayed
05 Nov, 4:54 pm GMT+0
AURX details
AURX Market Signals